Four countries reported more vaccine-derived polio cases in ongoing outbreaks, according to the latest weekly update today from the Global Polio Eradication Initiative (GPEI) today.
Public Health England (PHE) today confirmed that a person in the southwest of England has been diagnosed as having monkeypox, likely contracted after a recent visit to Nigeria.
The United Kingdom documented its first cases of the rare virus last year, in two patients who also likely contracted the disease in Nigeria, plus a case involving a healthcare worker—the first instance of spread of the disease in the country.
A study shows four out of five people with recent loss of smell and/or taste tested positive for COVID-19 antibodies, and 39.8% of those did not have a cough or fever.
A surveillance study of US children during the first wave of the pandemic found that multisystem inflammatory syndrome in children (MIS-C) was a rare complication associated with SARS-CoV-2 infection, but incidence was significantly higher in non-White racial and ethnic groups, US researchers reported yesterday in JAMA Network Open.
A randomized, controlled trial of 400 adults hospitalized for COVID-19–related respiratory failure suggests that awake prone positioning doesn't significantly reduce the need for endotracheal intubation at 30 days, but the authors caution that the effect size was imprecise and a therapeutic benefit cannot be ruled out.
Machine-learning models created by a National Institutes of Health (NIH)-supported research team can identify, with high accuracy, patients likely to have long COVID, according to a study yesterday in The Lancet Digital Health.
Rates of COVID-19 hospitalization among adult Medicare beneficiaries with disabilities were almost 50% higher than rates among elderly beneficiaries with no disability, according to a study today in Morbidity and Mortality Weekly Report (MMWR).
The United Kingdom today expanded monkeypox vaccination to include men who have sex with men who are in high-risk groups, instead of just those who are known contacts and those at occupational risk.
The US Centers for Disease Control and Prevention (CDC) yesterday reported 29 more monkeypox cases, raising the nation's total to 142.
So far 24 states and the District of Columbia have reported cases, up from 21 in the CDC's last update. The most affected states include California, New York, Illinois, and Florida.
Almost half of New York women who had been trying to become pregnant before COVID-19 stopped trying during the first few months of the pandemic, according to survey results published in JAMA Network Open yesterday.
New research from the Mayo Clinic shows monoclonal antibodies reduce the risk of hospitalization 77% in 1,395 patients who had breakthrough COVID-19 infections. The research was published yesterday in the Journal of Infectious Diseases.
Half of patients hospitalized with severe COVID-19 across 302 UK hospitals developed one or more health complications within 28 days or discharge, according to a study yesterday in The Lancet.
Director-General Tedros Adhanom Ghebreyesus, PhD, of the World Health Organization (WHO) today said many European countries, including Germany and the Netherlands, were showing continued slowing of new monkeypox cases, while countries in the Americas (save for Canada) are still seeing increased case counts.
A new study from Germany shows no major differences in the clinical picture in those with or without HIV who contract monkeypox. The study, in HIV Medicine, was based on 546 monkeypox cases in Germany, which has one of the highest monkeypox case counts in Europe. The study is published in HIV Medicine.
One day after the United States said it would allow intradermal, fractional dosing of Bavarian Nordic's monkeypox vaccine, Jynneos, the World Health Organization (WHO) called for more trials on the practice.
Maine, which has confirmed only four monkeypox cases, today reported a case of the virus in a resident under the age of 18. No further details were released by the Maine Centers for Disease Control. Maine now joins California and Florida as states with pediatric cases.
Also, researchers in Spain detail a possible human-to-dog case.
At a World Health Organization (WHO) briefing today, Director-General Tedros Adhanom Ghebreyesus, PhD, said Uganda's government is making progress in its battle against Ebola, but he raised concerns about case detections outside the main hot spots.
A study of 2,126 vaccine recipients identifies 10 cardiac events that all had alternative explanations, and no hospitalizations.
Boston public schools (BPS) yesterday announced the first monkeypox case in an "adult member of the BPS community," according to a letter sent to parents. The school district said the person was isolating at home, and the district was working to identify exposed individuals.
The COVID-19 pandemic dramatically worsened disparities in all-cause death rates for American Indian and Alaska Native (AIAN), Native Hawaiian, other Pacific Islander (NHOPI), and Black Americans and eroded mortality advantages for Asian and Hispanic groups, finds a study published yesterday in PNAS.
In a study published in Open Forum Infectious Diseases, researchers showed canine olfaction—or dog sniffing—was both highly sensitive and specific when it came to identifying patients with COVID-19, even those who were asymptomatic or presymptomatic.
In other mpox developments, Africa CDC noted a worrying rise in Kinshasa and the WHO listed the first mpox test for emergency use.
The DRC has reported more than 30,000 suspected and laboratory-confirmed mpox cases this year.
The detections push the number of African countries reporting mpox cases to 17.
A substantial proportion of mpox infections were clinically undiagnosed.
